Abstract: Embodiments of the present disclosure provide a method and apparatus for multi-input multi-output MIMO communications in a wireless communication network. The method comprises: receiving, from a device, long-term precoding information for the MIMO communication, the long-term precoding information indicating a first group of beams for a first antenna polarization, and a second group of beams for a second antenna polarization (S201); receiving, from the device, short-term precoding information for use in the MIMO communication, the short-term precoding information indicating beams selected respectively from the first group of beams and the second group of beams for different antenna polarizations (S202); constructing a precoding matrix for the MIMO communication according to the long-term precoding information and short-term precoding information (S203); and transmitting data encoded according to the precoding matrix to the device (S204).

Abstract: The present disclosure provides a method and apparatus for generating a codebook for wireless communication, a method and apparatus for generating a precoder for a 3D channel using the codebook in a base station in wireless communication, and a method and apparatus for facilitating generation of a precoder for the codebook in a user equipment in wireless communication. Compared with the prior art, the codebook provided by the present disclosure may be utilized for both horizontal beamforming and vertical beamforming. Compared with traditional precoders, the precoder provided by the present disclosure may control azimuth and downtilt angles of beams. Compared with the prior art, the present disclosure enhances system performance by exploiting vertical spatial gain of the 3D channel.

Abstract: The invention relates to a process for forming a cobalt-iron alloy film. In particular, the process is performed under ultrasonic vibrations to form the cobalt-iron alloy film. The cobalt-iron alloy film consists of about 75-95 wt. % of cobalt, 4.5-20 wt. % of iron and 0.5-5 wt. % of phosphorus and also has peaks at about 43.2, 45.1, 50.4, 65.5, 74.1 and 83.2 2-theta degree (2?) in the X-ray diffraction pattern.

Abstract: A light emitting device, an optical module and a manufacturing method thereof are disclosed. According to an example of the disclosure, the light emitting device may comprise an optical waveguide chip, a light emitting chip and a grating between the light emitting chip and the optical waveguide chip. The light emitting chip may emit laser light. The grating may couple the laser light emitted from the active layer into the optical waveguide chip in a way that the laser light is output along a length direction of the optical waveguide chip.

Abstract: The present invention relates to a method and an apparatus for quantizing channel state information (CSI). According to an embodiment of the present invention, a method for quantizing CSI is provided, which can be implemented on a base station side. The method includes: broadcasting antenna configuration of a base station to a user equipment, wherein the antenna configuration includes an antenna port in a vertical direction and an antenna port in a horizontal direction; sending a reference signal (RS) to the user equipment; receiving a vertical precoder corresponding to the antenna port in a vertical direction and a horizontal precoder corresponding to the antenna port in a horizontal direction that are fed back by the user equipment; and based on the received vertical precoder and horizontal precoder, reconstructing a precoder by using a vertical codebook corresponding to the antenna port in a vertical direction and a horizontal codebook corresponding to the antenna port in a horizontal direction.

Abstract: The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.

Abstract: A shuttle van system for a container terminal, including: at least one rail and a transfer device. The transfer device includes a plurality of shuttle vans and a plurality of transition platforms. Each shuttle van includes: a base frame, a wheel group, a wheel driving device, a lifting device, and a supporting plate. Each transition platform includes brackets. The shuttle vans run on the rail between the brackets. The lifting device of the shuttle van is configured to lift the container from the supporting plate. The container is transferred from the supporting plate of the shuttle van to the bracket after contraction of the lifting device.

Abstract: According to one embodiment of the present invention, a system processes a database query, and comprises a computer system including at least one processor. The system identifies one or more expressions within the database query utilizing a database object with value masking. Masking requirements are determined for each identified expression and the database object utilized by that identified expression is replicated to provide masked and actual versions of that database object in response to the masking requirements for that expression including masked values and actual values of that database object. The value masking of the database object is applied to the identified expressions within the database query based on the determined masking requirements to produce search results with masked values for the database query. Embodiments of the present invention further include a method and computer program product for processing a database query in substantially the same manner described above.

Abstract: The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalac

Abstract: The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.

Abstract: The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.

Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (I) as follows: wherein Y, Z, and R are defined herein.

Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (I) as follows: wherein Y, Z, and R are defined herein.

Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (I) as follows: wherein Y, Z, and R are defined herein.

Abstract: According to one embodiment of the present invention, a system processes a database query, and comprises a computer system including at least one processor. The system identifies one or more expressions within the database query utilizing a database object with value masking. Masking requirements are determined for each identified expression and the database object utilized by that identified expression is replicated to provide masked and actual versions of that database object in response to the masking requirements for that expression including masked values and actual values of that database object. The value masking of the database object is applied to the identified expressions within the database query based on the determined masking requirements to produce search results with masked values for the database query. Embodiments of the present invention further include a method and computer program product for processing a database query in substantially the same manner described above.

Abstract: Described is a technology in which new words (including a phrase or set of Chinese characters) are mined from a query log. The new words may be added to (or otherwise supplement) an IME dictionary. A set of candidate queries may be selected from the log based upon market (e.g., the Chinese market) and/or by language. From this set, various filtering steps are performed to locate only new words that are frequently in used. For example, only frequent queries are kept for further processing, which may include filtering out queries based on length (e.g., less than two or greater than eight Chinese characters), and/or filtering out queries based on too many stop-words in the query. Processing may also include filtering out a query that is a substring of a larger query, or vice-versa. Also described is Pinyin-based clustering and filtering, and filtering out queries already handled in the dictionary.

Abstract: The present invention is a process for the preparation of chymase modulators, useful in the treatment of inflammatory and serine protease mediated disorders.

Abstract: The present invention is a process for the preparation of chymase modulators, useful in the treatment of inflammatory and serine protease mediated disorders.

Abstract: The present invention is directed to a process, having a reduced environmental impact, for preparing phenylamino substituted quaternary salt compounds that are CCR2 antagonists.

Abstract: The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalac